At present, there is no provision under Drugs Rules, 1945 to address issues of wrong information to obtain regulatory approvals. Kindly note the image has been published only for representational......
Drug maker Ranbaxy Laboratories, which recently pleaded guilty of making fraudulent statements to the US Food and Drugs Administration and agreed to pay $500 million as penalty, now believes the......
Last week, Ranbaxy, India's largest drug maker by sales, recalled batches of the generic version of cholesterol-lowering drug Lipitor from the US market, after it suspected the presence of foreign......
After completion of its mandatory tender offer in Fortis Healthcare and Fortis Malar Hospitals, Malaysian heĀalth care giant IHH Healthcare is aiming to add 2,000 beds in a bid to double down on......
D S Brar on Monday announced his decision to step down as chief executive officer and managing director of Ranbaxy when his term expires on July 04, 2004 even as the company board named Brian......
In August, the ED had raided the residential premises of former Ranbaxy CEO Malvinder Mohan Singh and his brother Shivinder Singh in connection with a money laundering case. Economic Offences Wing......